亿胜生物(01061.HK)参展亚太眼科学会年会 报告贝伐珠单抗候选药物临床数据

阿斯达克财经
Feb 10

亿胜生物(01061.HK) 公布,成功参展于2026年2月5日至8日在香港会议展览中心举办的第41届亚太眼科学会年会(APAO 2026)。公司的海报研究《贝伐珠单抗与雷珠单抗治疗湿性年龄相关性黄斑变性的解剖学及患者报告结局:AURA-1研究》获选大会口头报告。该报告基于贝伐珠单抗候选药物(EB12-20145P)的III期临床数据,重点阐述了集团在湿性年龄相关性黄斑变性(wAMD)抗血管内皮...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10